Potential Roles of Kleinhovia hospita L. Leaf Extract in Reducing Doxorubicin Acute Hepatic, Cardiac and Renal Toxicities in Rats

Articles

Abstract
Pharmacognosy Research,2017,9,2,168-173.
Published:April 2017
Type:Original Article
Authors:
Author(s) affiliations:

Yulia Yusrini Djabir1, M Aryadi Arsyad2, Sartini Sartini3, Subehan Lallo4

1Laboratory of Clinical Pharmacy, Faculty of Pharmacy, Hasanuddin University, Makassar, INDONESIA.

2Department of Physiology, Faculty of Medicine, Hasanuddin University, Makassar, INDONESIA.

3Laboratory of Microbiology, Faculty of Pharmacy, Hasanuddin University, Makassar, INDONESIA.

4Laboratory Phytochemistry, Faculty of Pharmacy, Hasanuddin University, Makassar, INDONESIA.

Abstract:

Background: Doxorubicin (DOX) is a potent chemotherapy agent; however, its use may lead to cardiac, hepatic, and renal dysfunction. Kleinhovia hospita L extract contains antioxidant compounds that have been shown to reduce chemical-induced hepatotoxicity. Objectives: This study aimed to examine the protective effects of Kleinhovia sp. extract to reduce DOX acute toxicities. Materials and Methods: Thirty male rats were assigned to the following groups: Group I as controls, Group II was given DOX i.p. injection (25 mg/kg); Groups III, IV, and V were treated with Kleinhovia sp. extract 100, 250, and 500 mg/kg orally for 5 days, respectively, prior to DOX i.p. injection. After 24 h, blood and organs were analyzed for biomarker levels and histopathological changes. Results: DOX treatment in Group II significantly increased creatine kinase-MB (CK-MB), aspartate transaminase (AST), alanine transaminase (ALT), and urea levels compared to controls. Kleinhovia sp. extract at any given dose significantly improved ALT and AST; yet, CK-MB levels only reduced with 250 mg/kg dose (Group IV). Urea and creatinine levels in Kleinhovia sp. groups were also lower compared to DOX-treated rats, but it was not significant. Histopathological analysis showed improved liver, heart, and renal tissue structures in Kleinhovia sp-treated rats, especially at higher doses. Conclusion: Kleinhovia sp. extract at any dose given protected the rats from liver toxicity, but only at dose 250 mg/kg reduced cardiac toxicity. Although renal biomarkers were insignificantly lower, renal architecture was improved with Kleinhovia sp. treatment.

PDF
Current View
Click here to download the PDF file.
Images

Diagram of experimental protocols. Animals were adapted for 14 days prior to Kleinhovia sp. extract administration for 5 consecutive days. At day 5, rats were injected with either saline or doxorubicin. After 24 h, blood was withdrawn and organs were harvested for further analysis

Keywords